Matrine suppressed the proliferation of MCF-7/ADR cells, triggered apoptosis, and counteracted the development of multidrug resistance in breast cancer cells. This was achieved via modulating the downstream apoptotic components of the PI3K/AKT signaling pathway, resulting in a reduction in the phosphorylation of AKT levels in the cells. The gene discussed is AKT1; the disease is breast cancer.